NYSE:USNA USANA Health Sciences (USNA) Stock Price, News & Analysis $27.04 +1.61 (+6.33%) As of 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About USANA Health Sciences Stock (NYSE:USNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get USANA Health Sciences alerts:Sign Up Key Stats Today's Range$25.02▼$27.1650-Day Range$23.51▼$33.1852-Week Range$23.10▼$49.78Volume306,366 shsAverage Volume121,192 shsMarket Capitalization$511.19 millionP/E Ratio9.55Dividend YieldN/APrice Target$36.00Consensus RatingHold Company OverviewUSANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.Read More… USANA Health Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks94th Percentile Overall ScoreUSNA MarketRank™: USANA Health Sciences scored higher than 94% of companies evaluated by MarketBeat, and ranked 71st out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingUSANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageUSANA Health Sciences has only been the subject of 2 research reports in the past 90 days.Read more about USANA Health Sciences' stock forecast and price target. Earnings and Valuation4.4 / 5Proj. Earnings Growth17.96% Earnings GrowthEarnings for USANA Health Sciences are expected to grow by 17.96% in the coming year, from $2.45 to $2.89 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of USANA Health Sciences is 9.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.67.Price to Earnings Ratio vs. SectorThe P/E ratio of USANA Health Sciences is 9.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.18.Price to Earnings Growth RatioUSANA Health Sciences has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioUSANA Health Sciences has a P/B Ratio of 1.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.81% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 10.87%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUSANA Health Sciences does not currently pay a dividend.Dividend GrowthUSANA Health Sciences does not have a long track record of dividend growth. Sustainability and ESG3.2 / 5Environmental Score-2.09 Percentage of Shares Shorted6.81% of the float of USANA Health Sciences has been sold short.Short Interest Ratio / Days to CoverUSANA Health Sciences has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in USANA Health Sciences has recently decreased by 10.87%, indicating that investor sentiment is improving significantly. News and Social Media1.9 / 5News Sentiment0.34 News SentimentUSANA Health Sciences has a news sentiment score of 0.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 22 news articles for USANA Health Sciences this week, compared to 4 articles on an average week.MarketBeat FollowsOnly 2 people have added USANA Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $500,285.00 in company stock.Percentage Held by InsidersOnly 0.63% of the stock of USANA Health Sciences is held by insiders.Percentage Held by Institutions54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about USANA Health Sciences' insider trading history. Receive USNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address USNA Stock News HeadlinesUsana Health Sciences Inc (USNA) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ...April 24 at 11:21 AM | finance.yahoo.comUSANA Health Sciences Sees Sales Growth Amid Earnings DeclineApril 24 at 12:21 AM | tipranks.comThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside and write a book about it. This isn't just another Bitcoin prediction – it's a complete roadmap for what I believe will be the biggest wealth-building opportunity of this decade. The evidence is so compelling, I'm doing something that probably seems insane: I'm giving away my entire book for free. April 24, 2025 | Crypto 101 Media (Ad)Q1 2025 USANA Health Sciences Inc Earnings Call TranscriptApril 24 at 12:21 AM | gurufocus.comUSANA Philippines Named Among Most Trusted Brands by Reader's DigestApril 23 at 9:11 PM | finance.yahoo.comExploring Usana Health Sciences's Earnings ExpectationsApril 23 at 4:08 PM | nasdaq.comUSANA Health Sciences posts mixed Q1 results, strong guidanceApril 23 at 4:08 PM | investing.comUSANA (NYSE:USNA) Exceeds Q1 Expectations, Full-Year Sales Guidance is OptimisticApril 23 at 4:08 PM | msn.comSee More Headlines USNA Stock Analysis - Frequently Asked Questions How have USNA shares performed this year? USANA Health Sciences' stock was trading at $35.89 at the beginning of the year. Since then, USNA shares have decreased by 24.7% and is now trading at $27.04. View the best growth stocks for 2025 here. How were USANA Health Sciences' earnings last quarter? USANA Health Sciences, Inc. (NYSE:USNA) posted its earnings results on Tuesday, April, 22nd. The company reported $0.73 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.03. The firm had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. USANA Health Sciences had a net margin of 6.30% and a trailing twelve-month return on equity of 10.64%. Read the conference call transcript. Who are USANA Health Sciences' major shareholders? USANA Health Sciences' top institutional investors include Assenagon Asset Management S.A. (0.55%), Rhumbline Advisers (0.19%), Robeco Institutional Asset Management B.V. (0.10%) and Exchange Traded Concepts LLC (0.05%). Insiders that own company stock include Myron W Wentz, Jim Brown, David Mulham Mulham, Kevin Guest, John Turman Fleming, Peggie Pelosi, Frederic J Winssinger, Xia Ding, Daniel A Macuga, Paul A Jones, Robert A Sinnott, Gilbert A Fuller, Joshua Foukas, Walter Noot, G Doug Iiekking and Brent Neidig. View institutional ownership trends. How do I buy shares of USANA Health Sciences? Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of USANA Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX). Company Calendar Last Earnings4/22/2025Today4/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medicinals & botanicals Sub-IndustryPersonal Products Current SymbolNYSE:USNA CIK896264 Webwww.usana.com Phone(801) 954-7100Fax801-954-7300Employees1,900Year FoundedN/APrice Target and Rating Average Stock Price Target$36.00 High Stock Price Target$36.00 Low Stock Price Target$36.00 Potential Upside/Downside+34.8%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$2.19 Trailing P/E Ratio9.46 Forward P/E Ratio10.90 P/E Growth0.93Net Income$63.79 million Net Margins6.30% Pretax Margin10.73% Return on Equity10.64% Return on Assets8.48% Debt Debt-to-Equity RatioN/A Current Ratio3.93 Quick Ratio3.37 Sales & Book Value Annual Sales$854.50 million Price / Sales0.59 Cash Flow$3.66 per share Price / Cash Flow7.29 Book Value$25.99 per share Price / Book1.03Miscellaneous Outstanding Shares18,905,000Free Float18,997,000Market Cap$504.95 million OptionableOptionable Beta1.00 Social Links 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleLooking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.Get This Free Report This page (NYSE:USNA) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.